IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans

Richard J. Albertini, Diana Anderson, George R. Douglas, Lars Hagmar, Kari Hemminki, Franco Merlo, A. T. Natarajan, Hannu Norppa, David E G Shuker, Raymond Tice, Michael D. Waters, Antero Aitio

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of these guidelines is to provide concise guidance on the planning, performing and interpretation of studies to monitor groups or individuals exposed to genotoxic agents. Most human carcinogens are genotoxic but not all genotoxic agents have been shown to be carcinogenic in humans. Although the main interest in these studies is due to the association of genotoxicity with carcinogenicity, there is also an inherent interest in monitoring human genotoxicity independently of cancer as an endpoint.The most often studied genotoxicity endpoints have been selected for inclusion in this document and they are structural and numerical chromosomal aberrations assessed using cytogenetic methods (classical chromosomal aberration analysis (CA), fluorescence in situ hybridisation (FISH), micronuclei (MN)); DNA damage (adducts, strand breaks, crosslinking, alkali-labile sites) assessed using bio-chemical/electrophoretic assays or sister chromatid exchanges (SCE); protein adducts; and hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutations. The document does not consider germ cells or gene mutation assays other than HPRT or markers of oxidative stress, which have been applied on a more limited scale. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)111-172
Number of pages62
JournalMutation Research - Reviews in Mutation Research
Volume463
Issue number2
DOIs
Publication statusPublished - Aug 2000

Keywords

  • Biomarkers
  • Biomonitoring
  • Genotoxic carcinogens
  • Guideline
  • Human populations
  • WHO

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis

Fingerprint Dive into the research topics of 'IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans'. Together they form a unique fingerprint.

Cite this